GBA in Parkinson's disease: variant detection and pathogenicity scoring matters
Gabbert, C.; Schaake, S.; Lüth, T.; Much, C.; Klein, C.; Aasly, J. O.; Farrer, M. J.; Trinh, J.
Show abstract
BackgroundGBA variants are the strongest genetic risk factor for Parkinsons disease (PD). However, the pathogenicity of GBA variants concerning PD is still not fully understood. Additionally, the frequency of GBA variants varies widely across populations. ObjectivesTo evaluate Oxford Nanopore sequencing as a strategy, to determine the frequency of GBA variants in Norwegian PD patients and controls, and to review the current literature on newly identified variants that add to pathogenicity determination. MethodsWe included 462 Norwegian PD patients and 367 healthy controls. We sequenced the full-length GBA gene on the Oxford Nanopore GridION as an 8.9 kb amplicon. Six analysis pipelines were compared using two aligners (NGMLR, Minimap2) and three variant callers (BCFtools, Clair3, Pepper-Margin-Deepvariant). Confirmation of GBA variants was performed by Sanger sequencing and the pathogenicity of variants was evaluated. ResultsWe found 95.8% (115/120) true-positive GBA variant calls, while 4.2% (5/120) variant calls were false-positive, with the NGMLR/Minimap2-BCFtools pipeline performing best. In total, 13 rare GBA variants were detected: two were predicted to be (likely) pathogenic and eleven were of uncertain significance. The odds of carrying one of the two most common GBA variants, p.L483P or p.N409S, in PD patients were estimated to be 4.11 times the odds of carrying one of these variants in controls (OR=4.11 [1.39, 12.12]). ConclusionsIn conclusion, we have demonstrated that Oxford long-read Nanopore sequencing, along with the NGMLR/Minimap2-BCFtools pipeline is an effective tool to investigate GBA variants. Further studies on the pathogenicity of GBA variants are needed to assess their effect on PD.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson's disease 93%
- Remote monitoring of progression in early Parkinson’s disease: reliability and validity of the Roche PD Mobile Application v2 92%
- MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson's HLA locus exhibits epigenetic regulation 91%
Similar papers in this journal
- Biallelic truncation variants in ATP9A are associated with a novel autosomal recessive neurodevelopmental disorder 91%
- Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses 90%
- Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort 90%
Similar papers in this journal
- Genome-Wide Sequencing as a First-Tier Screening Test for Short Tandem Repeat Expansions 90%
- Evaluating Genome Sequencing Strategies: Trio, Singleton, and Standard Testing in Rare Disease Diagnosis 90%
- DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs) 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.